Global /Japan /Healthcare /Drug Manufacturers - Specialty & Generic /4595
chevron_leftBack

Mizuho Medy Co.,Ltd.

4595
TSE: 4595 Delayed
1,496JPY 0.4%
10.45 USD
As of 24 April 2025, Mizuho Medy Co.,Ltd. has a market cap of $199.19M USD, ranking #17214 globally and #1620 in Japan. It ranks #1710 in the Healthcare sector, and #412 in the Drug Manufacturers - Specialty & Generic industry.
Global Rank
17214
Country Rank
1620
Sector Rank
1710
Industry Rank
412
Key Stats
Market Cap
$199.19MUSD
28.38B JPY
Enterprise Value
$119.74MUSD
17.14B JPY
Revenue (TTM)
$80.21MUSD
11.43B JPY
EBITDA (TTM)
$35.96MUSD
5.15B JPY
Net Income (TTM)
$26.48MUSD
3.77B JPY
EBITDA Margin
45%
Profit Margin
33%
PE Ratio
7.5
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Fuminari Karakawa open_in_new
Employees
187
Founded
1977
Website
mizuho-m.co.jp open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
0.4% 2.7% 0.9% 6.2% -7.5% -9.1%
Upcoming Earnings
Earnings Date
Fri, May 9

Markets

Exchange Ticker Price
Tokyo Stock Exchange
MIC: XTKS
PRIMARY
4595
ミズホメディー
ISIN: JP3885900005
Shares Out.:
19.049M1 Shares Float: 12.211M2
TV:
SA:
YF:
GF:
BA:
MS:
1.5K JPY
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Mizuho Medy Co.,Ltd.

Mizuho Medy Co.,Ltd. researches and develops, manufactures, and sells in-vitro diagnostic products and related scientific and technical information services primarily in Japan. The company provides immunoassay test products, such as influenza virus kits; RS virus and human metapneumovirus antigen test kits; streptococcus pneumoniae antigen and legionella antigen test kits; mycoplasma pneumoniae antigen test kits; adenovirus antigen test kits; rotavirus and adenovirus antigen test kits; norovirus antigen test kits; group a streptococcal antigen test kits; pregnancy test kits; ovulation test kits; and fecal occult blood test kits. It also offers gene analysis instrument; SARS-CoV-2 detection kits; and mycoplasma pneumoniae nucleic acid kits. In addition, the company engages in import and export activities. It also operates in the United States, Belgium, Finland, Netherlands, Taiwan, Thailand, etc. Mizuho Medy Co.,Ltd. was incorporated in 1977 and is headquartered in Tosu, Japan.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (Japan)
Name
Market Cap diff.
Takeda Pharmaceutical Company Ltd.
4502
$46.31B
6.6T JPY
23K%
Shionogi & Co., Ltd.
4507
$14.44B
2.06T JPY
7K%
Eisai Co., Ltd.
4523
$8.06B
1.15T JPY
4K%
Hisamitsu Pharmaceutical Co., Inc.
4530
$2.3B
328.11B JPY
1K%
Tsumura & Co.
4540
$2.29B
325.8B JPY
1K%
Industry: Drug Manufacturers - Specialty & Generic (Global)
Name
Market Cap diff.
Zoetis Inc.
ZTS
$67.32B
34K%
Merck KGaA
MRK
$59.42B
52.43B EUR
30K%
Sun Pharmaceutical Industries Ltd.
SUNPHARMA
$49.13B
4.19T INR
25K%
Haleon plc
HLN
$45.57B
34.34B GBP
23K%
Galderma Group AG
GALD
$23.06B
19.13B CHF
11K%